China Jo-Jo Drugstores, Inc.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: KYG2124G1120
USD
3.97
0.04 (1.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About China Jo-Jo Drugstores, Inc. stock-summary
stock-summary
China Jo-Jo Drugstores, Inc.
Retailing
China Jo-Jo Drugstores Inc is a China-based company principally engaged in the retail and distribution of pharmaceutical and other healthcare products. The Company operates its business through four segments. The Retail Drugstores segment sells prescription and over-the-counter (OTC) drugs, nutritional supplements, traditional Chinese medicine (TCM), personal and family care products, medical devices, and convenience products, including consumable, seasonal, and promotional items. The Online Pharmacy segment sells certain OTC drugs, medical devices, nutritional supplements and other sundry products through third-party platforms such as Alibaba’s Tmall, JD.com and Amazon.com, and the Company’s own platform all over China. The Drug Wholesale segment supplies its own retail drugstores with prescription and OTC medicines, TCM, dietary supplement, medical devices and sundry items. The Herb Farming segment cultivates selected herbs for sales to other drug vendors.
Company Coordinates stock-summary
Company Details
Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou HANGZHOU ZHJ : 310008
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.31%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lei Liu
Chairman of the Board, Chief Executive Officer
Ms. Li Qi
Director
Dr. Genghua Gu
Independent Director
Mr. Jiangliang He
Independent Director
Ms. Caroline Wang
Independent Director
Ms. Pingfan Wu
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
36 Million
(Quarterly Results - Mar 2021)
Net Profit:
0 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 9 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

-27.71%

stock-summary
Price to Book

0.29